Drug intelligence / Profile preview

tetanus vaccine

Development stage
Approved
Lead developer
AIM Vaccine Co.
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Tetanus vaccine is a biologic preparation used to induce active immunity against tetanus, a severe disease caused by the neurotoxin tetanospasmin produced by *Clostridium tetani*. The vaccine typically consists of tetanus toxoid, which is the bacterial toxin that has been inactivated (usually with formaldehyde) to eliminate toxicity while preserving its ability to stimulate an immune response. The specific investigational product described in the context is an adsorbed tetanus vaccine developed by AIM Vaccine Co., Ltd. (Aimei Vacin BioPharm), which is currently in Phase I clinical trials to evaluate safety and immunogenicity in healthy adults. Adsorption to aluminum salts (alum) is a common formulation strategy used to enhance the vaccine's immunogenicity by acting as an adjuvant.

Other names
tetanus toxoidAdsorbed Tetanus Vaccinetetanus toxoid vaccine
02

Targets

TT (Tetanus toxoid)

Beyond the preview

Go deeper on tetanus vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetanus vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call